Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1575 of 5804
-
Talking away the pain: CBT may stop chronic pain after broken bones
Symptom relief CompletedPsychological factors such as stress, distress, anxiety, depression, and poor coping strategies may be associated with ongoing pain following injuries such as fractures. To study this relationship, patients will undergo cognitive behavioural therapy (CBT) which is designed to mod…
Phase: NA • Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 26, 2026 14:00 UTC
-
TENS device shows promise for fibromyalgia pain relief in major trial
Symptom relief CompletedThe purpose of this study is to determine if addition of Transcutaneous Electrical Nerve Stimulation (TENS) to routine physical therapy improves movement-evoked pain in patients with fibromyalgia (FM). The study will also determine if addition of TENS to routine physical therapy…
Phase: PHASE3 • Sponsor: Kathleen Sluka • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Personalized blood clot prevention for pregnant women put to the test
Prevention Recruiting nowThe management of venous thromboembolism (VTE) risk in pregnancy still remains a challenge. An individual assessment of the VTE risk is crucial for optimal thromboprophylaxis, but there is no validated tool to help clinicians stratify the risk in pregnant women and introduce prop…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
New hope for Hard-to-Treat cancers? utidelone trial underway
Disease control CompletedThis trial is an open, two-stage, multi-center, phase II clinical trial to evaluate the efficacy and safety of Utidelone in advanced solid tumors (excluding breast cancer, lung cancer, and colorectal cancer) that have failed standard of treatment or were unable to perform standar…
Phase: PHASE2 • Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Moldable bone putty could improve spine surgery outcomes
Disease control Recruiting nowThe primary objective of this study is to measure the success rate of lumbar fusion in subjects at 12 months when instrumented lumbar arthrodesis is performed using OssiMend Bioactive Moldable as the bone grafting material
Sponsor: Collagen Matrix • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Hope for dravet syndrome: Long-Term safety trial of STK-001 underway
Disease control OngoingStoke Therapeutics is evaluating the long-term safety \& tolerability of repeated doses of zorevunersen (STK-001) in patients with Dravet syndrome who previously participated in studies of zorevunersen. Change in seizure frequency and overall clinical status, and quality of life …
Phase: PHASE2 • Sponsor: Stoke Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New imaging trial aims to sharpen diagnosis for Parkinson's, tumors, and more
Diagnosis Recruiting nowA single centre non-randomized, non-blinded phase III prospective cohort study of 18F-DOPA PET/CT imaging in specific patient populations: 1. Pediatric patients (less than 18 years old) with congenital hyperinsulinism. 2. Pediatric patients (less than 18 years old) with neurobla…
Phase: PHASE3 • Sponsor: University of Alberta • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Immunotherapy combo shows promise for Hard-to-Treat prostate cancer
Disease control CompletedThe purpose of this study is to evaluate the effects of 4 cycles of combinatory immunotherapy (ipilimumab and nivolumab), followed by monotherapy nivolumab in participants with immunogenic metastatic castration-resistant prostate cancer.
Phase: PHASE2 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a common diabetes drug tame a tricky heart rhythm?
Disease control CompletedThis clinical trial is being done to determine if metformin, a drug which is normally used in diabetes, can reduce atrial fibrillation in patients who are having an ablation for atrial fibrillation (AF). Atrial fibrillation is an abnormal heart rhythm which research has shown is …
Phase: PHASE4 • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Ancient herb may help heart patients shed excess fluid
Symptom relief OngoingThe objective of the GOREISAN-HF trial is to assess the effect of the administration of Goreisan (TJ-17) plus standard therapy compared to standard therapy alone on the improvement rate of cardiac edema and clinical outcomes in worsening congestive heart failure with volume overl…
Phase: PHASE4 • Sponsor: Takeshi Morimoto • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Can early intensive therapy boost motor skills in kids with cerebral palsy?
Disease control CompletedOne of the urgent priorities in the field of pediatric neuro-rehabilitation is the development of efficient early motor interventions for children with cerebral palsy (CP). Animal studies suggest that early intensive interventions are likely to have a significant impact on the or…
Phase: NA • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Balloon treatment aims to defuse 'Time Bomb' plaques in heart arteries
Disease control CompletedRationale: Two-thirds of intracoronary thrombi causing acute coronary syndrome (ACS) result from rupture of lipid-rich plaques (LRP). After treatment of the culprit lesion in ACS patients, additional LRPs are found in approximately 50% of patients. Near infrared spectroscopy (NIR…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Blood tests could guide oxygen therapy for severe brain injury
Knowledge-focused Recruiting nowThere are no therapeutic agents that have been shown to improve outcomes from severe traumatic brain injury (TBI). Critical barriers to progress in developing treatments for severe TBI are the lack of: 1) monitoring biomarkers for assessing individual patient response to treatmen…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Skin cancer survivors test cream combo to stop new tumors
Prevention CompletedThis is a single institution, randomized, placebo-controlled, double-blind phase IIB trial of 1) topical diclofenac and topical DFMO, or 2) placebo in participants with a history of non melanoma skin cancer/ keratinocytic cancers.
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
Personal support boosts heart recovery in women
Disease control CompletedOutpatient cardiac rehabilitation (CR) is an exercise-based lifestyle program for patients who have experienced a myocardial infarction, systolic heart failure, percutaneous revascularization or cardiac surgery. CR plays a key role in secondary prevention, which is the prevention…
Phase: NA • Sponsor: University of Vermont Medical Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug aims to stop the agonizing itch of dialysis
Symptom relief CompletedDouble-blind, Placebo-controlled study to confirm the superiority of MR13A9 to placebo, and followed by extension, open-label treatment to confirm long-term safety of MA13A9 in hemodialysis patients with pruritus.
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 15:55 UTC
-
Could zapping a different brain region tame epilepsy?
Disease control OngoingDeep brain stimulation (DBS) is one of the neuromodulation techniques that can be indicated in patients suffering from refractory epilepsies, especially when an open resection has failed or is not indicated, and vagal nerve stimulation (VNS) demonstrated no efficacy. Benefits suc…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Electric pacing device aims to restore breathing and voice in paralyzed larynx patients
Disease control OngoingThe primary purpose of this project is to evaluate the safety of new treatment termed bilateral laryngeal pacing to improve treatment outcomes in patients with bilateral vocal fold paralysis (BVFP) (Aim 1). Outcome measures related to voice and ventilation will also provide initi…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Experimental immune cell therapy shows promise for tough blood cancers
Disease control CompletedThe purpose of the study is to determine the safety of an investigational treatment for myelodysplastic syndrome (MDS) after the first therapy (such as azacitidine or decitabine) stops working or after progression of MDS to acute myeloid leukemia (AML). Funding source - FDA OOPD.
Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Brain stimulation trial targets depression in autistic teens
Symptom relief Recruiting nowThe current clinical trial is focused on evaluating the efficacy of rTMS for treatment of depression in youth and young adults (hereafter called transition aged youth, TAY) with autism spectrum disorder (ASD). The motivation to undertake the current efficacy study is driven by: (…
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC